Sumitomo Pharma America, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1984-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.sunovion.com
Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause
- First Posted Date
- 2006-08-18
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 410
- Registration Number
- NCT00366093
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2006-08-03
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 171
- Registration Number
- NCT00359944
- Locations
- 🇺🇸
PsyPharma Clinical Research Inc., Phoenix, Arizona, United States
🇺🇸Pacific Research Network, San Diego, California, United States
🇺🇸Research Center of Florida Inc., Miami, Florida, United States
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 830
- Registration Number
- NCT00352144
Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB
- Conditions
- Interventions
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00268723
Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 443
- Registration Number
- NCT00250679
Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
- Conditions
- Interventions
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT00235508
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT00088621
- Locations
- 🇺🇸
Segal Institute for Clinical Research, North Miami, Florida, United States
🇺🇸Optimum Health Services, La Mesa, California, United States
🇺🇸Birmingham Psychiatry Pharmaceutical, Birmingham, Alabama, United States
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT00088634
- Locations
- 🇺🇸
Birmingham Psychiatry Pharmaceutical, Birmingham, Alabama, United States
🇺🇸Summit Research Group, Little Rock, Arkansas, United States
🇺🇸Comprehensive NeuroScience, Cerritos, California, United States
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- Conditions
- Interventions
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 445
- Registration Number
- NCT00073827
- Locations
- 🇺🇸
Clinical Research Centers of Colorado PC, Englewood, Colorado, United States
🇺🇸University of Maryland School of Medicine, Baltimore, Maryland, United States
🇺🇸Princeton Center for Clinical Research, Princeton, New Jersey, United States
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 386
- Registration Number
- NCT00073840
- Locations
- 🇺🇸
Aeroallergy Research Laboratories of Savannah, Inc., Savannah, Georgia, United States
🇺🇸Rush Presbyterian - St. Luke's Medical Center Rush University, Chicago, Illinois, United States
🇺🇸Research Across America, Dallas, Texas, United States